This book provides the latest findings on neuroprotection and neuroregeneration as potential therapeutic strategies for various eye diseases, namely, glaucoma, age-related macular degeneration (AMD), retinal detachment, and retinitis pigmentosa. Glaucoma is one of the main causes of blindness throughout the world, and other diseases such as AMD and retinitis pigmentosa also lead to loss of vision. All these conditions are characterized by degeneration of specific retinal cell types, making it essential to establish treatments to protect retinal neurons and the optic nerve. With that aim in…mehr
This book provides the latest findings on neuroprotection and neuroregeneration as potential therapeutic strategies for various eye diseases, namely, glaucoma, age-related macular degeneration (AMD), retinal detachment, and retinitis pigmentosa. Glaucoma is one of the main causes of blindness throughout the world, and other diseases such as AMD and retinitis pigmentosa also lead to loss of vision. All these conditions are characterized by degeneration of specific retinal cell types, making it essential to establish treatments to protect retinal neurons and the optic nerve.
With that aim in mind, this book explains the mechanisms underlying aforementioned diseases and their experimental models. The novel strategy proposals for the treatment of retinal diseases based on the concept of neuroprotection are also discussed in the main body of the text, while the section on regenerative research discusses optic nerve regeneration, endothelial progenitor cells, and iPScells.
This book is recommended as a professional reference work for all doctors and trainees in the field of ophthalmology who are interested in neuroprotective and neuroregenerative treatments.
Artikelnr. des Verlages: 86295493, 978-4-431-54964-2
2014
Seitenzahl: 368
Erscheinungstermin: 11. August 2014
Englisch
Abmessung: 241mm x 160mm x 26mm
Gewicht: 736g
ISBN-13: 9784431549642
ISBN-10: 4431549641
Artikelnr.: 40917666
Herstellerkennzeichnung
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Dr. Toru Nakazawa, MD, PhD. Department of Ophthalmology Tohoku University Graduate School of Medicine 1-1 Seiryo-cho Aoba-ku Sendai-shi Miyagi-ken 980-8574, Japan Dr. Yasushi Kitaoka, MD, PhD. Department of Ophthalmology, St. Marianna University School of Medicine 2-16-1 Sugao, Kawasaki-shi, Kanagawa 216-8511, Japan Dr. Takayuki Harada, MD, PhD. Visual Research Project Tokyo Metropolitan Institute of Medical Science 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan
Inhaltsangabe
Part I Neuroprotection for Glaucoma.- 1. Molecular Architecture of Glutamate Signaling Pathway in Glaucomatous Optic Neuropathy.- 2. Calcium and Calpain Activation.- 3. Classical Signaling Pathways.- 4. Antioxidative Treatment for Neuroprotection in Glaucoma.- 5. ER stress.- 6. Nitric Oxide Contributes to Retinal Ganglion Cell Survival Through Protein S-Nitrosylation after Optic Nerve Injury.- 7. Neurotrophic factors.- 8. RIP Kinase-Mediated Programmed Necrosis.- 9. Axonal Degeneration.- 10. Axonal Transport.- 11. Interaction Between RGC Bodies and Glia.- 12. Aquaporin in optic neuropathies.- 13. Microglia.- Part II Neuroprotection for Age-Related Macular Degeneration (AMD), Retinal Pigmentary Degeneration.- 14. Neuroprotection for Photoreceptors.- 15. Retinal Photooxidative Stress and Its Modifiers.- 16. Roles of the Retinal Pigment Epithelium in Neuroprotection.- 17. Oxidative Stress in the RPE and Its Contribution to AMD Pathogenesis; Implication of Light Exposure.- 18. Interaction Between Photoreceptors and RPEs.- Part III Neuroprotection for Other Retinal Diseases.- 19. Neuroprotection for Retinal Detachment.- 20. Neuroinflammation.- 21. Optic Neuritis.- 22. Neuroprotection by Endothelial Progenitor Cells for Retinal Degeneration.- 23. Optic Nerve Regeneration.
Part I Neuroprotection for Glaucoma.- 1. Molecular Architecture of Glutamate Signaling Pathway in Glaucomatous Optic Neuropathy.- 2. Calcium and Calpain Activation.- 3. Classical Signaling Pathways.- 4. Antioxidative Treatment for Neuroprotection in Glaucoma.- 5. ER stress.- 6. Nitric Oxide Contributes to Retinal Ganglion Cell Survival Through Protein S-Nitrosylation after Optic Nerve Injury.- 7. Neurotrophic factors.- 8. RIP Kinase-Mediated Programmed Necrosis.- 9. Axonal Degeneration.- 10. Axonal Transport.- 11. Interaction Between RGC Bodies and Glia.- 12. Aquaporin in optic neuropathies.- 13. Microglia.- Part II Neuroprotection for Age-Related Macular Degeneration (AMD), Retinal Pigmentary Degeneration.- 14. Neuroprotection for Photoreceptors.- 15. Retinal Photooxidative Stress and Its Modifiers.- 16. Roles of the Retinal Pigment Epithelium in Neuroprotection.- 17. Oxidative Stress in the RPE and Its Contribution to AMD Pathogenesis; Implication of Light Exposure.- 18. Interaction Between Photoreceptors and RPEs.- Part III Neuroprotection for Other Retinal Diseases.- 19. Neuroprotection for Retinal Detachment.- 20. Neuroinflammation.- 21. Optic Neuritis.- 22. Neuroprotection by Endothelial Progenitor Cells for Retinal Degeneration.- 23. Optic Nerve Regeneration.
Rezensionen
"The book summarizes and reviews recent research findings regarding neuroprotection and neuroregeneration for the treatment of macular degeneration, glaucoma, and retinal diseases. ... The intended audience is medical students, researchers, and ophthalmologists interested in ongoing ophthalmologic research. ... most likely will appeal to ophthalmologists specializing in retinal diseases or glaucoma and to ophthalmologic researchers. ... This is a useful review of the current literature and a convenient summary of ongoing research into macular degeneration, glaucoma, and retinal disease." (Caroline Minkus, Doody's Book Reviews, August, 2015)
"This is a great book on the molecular and cellular pathways in retinal diseases and their regeneration through gene, RNA, DNA, and hormonal interventions in human and animal models. ... I recommend this book to ophthalmologists, eye researcher, and physicians with an interest in Retina will benefit greatly." (Joseph J. Grenier, Amazon.com, October, 2014)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826